August 16, 2026 01:00 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
After SC rebuke, BCI chief apologises to NALSAR students over enrolment freeze row | Independence Day: PM Modi’s big youth pitch— AI training, free coaching amid exam row and job concerns | ‘Shakti Ki Saptadhara’: Modi reveals 7 pillars to power India’s next leap in his I-Day speech from Red Fort | West Bengal STF arrests 3 more suspected Pakistani spies in Cooch Behar | Bengal man arrested in Bengaluru over terror links, Afghanistan travel plan | Ajit Doval breaks silence on Operation Sindoor in Discovery’s explosive new docuseries | Rahul Gandhi's 'mock hug' taunt sparks row; Centre stresses 'mutual respect' with Italy | Delhi on high alert: Bomb threat to High Court, airport and multiple locations ahead of I-Day | ‘Who are they to interfere?’: CJI Surya Kant slams Bar Council of India over NALSAR students’ enrolment row | 'Shows how low Congress has sunk': BJP slams Rahul Gandhi over Modi foreign policy jibe
Image Credit : Photo: File/UNI

Govt asks Patanjali to explain ‘dubious’ transactions flagged by economic intelligence wing

| @indiablooms | May 30, 2025, at 05:10 pm

New Delhi: India’s Corporate Affairs Ministry has issued a notice to Patanjali Ayurved Ltd., the traditional medicine firm co-founded by yoga guru Baba Ramdev, seeking clarification over transactions considered suspicious, Bloomberg reported, citing people familiar with the matter.

The notice followed findings by the federal economic intelligence wing, which identified the transactions as “abnormal and dubious”, the people said, requesting anonymity due to regulatory protocols.

The individuals did not reveal the financial scale of the transactions, noting that the investigation remains at a preliminary stage.

According to them, the company has been granted approximately two months to submit a response.

Authorities will also probe potential breaches of corporate governance and possible diversion of funds, they added.

The Corporate Affairs Ministry did not immediately respond to a request for comment. Patanjali Ayurved has also yet to provide a statement.

This is not the first instance of regulatory scrutiny for Patanjali Ayurved or its subsidiaries.

Last year, one of its units was served show-cause notices by the government over alleged tax defaults and ineligible refund claims.

Separately, India’s Supreme Court barred the company from advertising its products as cures for illnesses such as cancer, citing violations of the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954.

In February 2025, Kerala’s Drugs Control Department reported 26 active cases across different courts in the state against Ramdev and Patanjali under the same advertisement law.

Several newspapers are also facing legal action for publishing the contentious ads.

While Patanjali Ayurved remains privately held, its listed arm, Patanjali Foods Ltd., has seen its shares fall nearly 10% so far this month.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.